Monday, June 22, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 236 of 1,261
  1. US 11458127

    Methods of treating brain tumors using combination therapy

    Agios Pharmaceuticals, Inc. · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  2. US 11459385

    Anti-IL-2 antibodies and compositions and uses thereof

    The Regents of the University of California · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  3. US 11459357

    Polymyxin compounds

    SPERO THERAPEUTICS, INC. · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  4. US 11459340

    Tri-substituted heteroaryl derivatives as Src homology-2 phosphatase inhibitors

    NIKANG THERAPEUTICS, INC. · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  5. US 11459373

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  6. US 11459593

    Dendrobium officinale endophytic fungus strain and extracellular polysaccharide produced thereby, and extraction method and application of extracellular polysaccharide

    South China University of Technology · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  7. US 11459325

    Heterocyclic compound

    Takeda Pharmaceutical Company Limited · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  8. US 11459560

    Methods and compositions for reprogramming cells

    The Regents of the University of Colorado · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  9. US 11459335

    N/O-linked Degrons and Degronimers for protein degradation

    C4 THERAPEUTICS, INC. · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  10. US 11459300

    Deuterated compounds and uses thereof

    Aldeyra Therapeutics, Inc. · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  11. US 11459360

    Recombinant HIV-1 envelope proteins and their use

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  12. US 11459320

    Deuterated Alpha5 subunit-selective negative allosteric modulators of gamma-aminobutyric acid type A receptors as fast acting treatment for depression and mood disorders

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  13. US 11459298

    Class of dicationic compounds as well as the preparative method and the use thereof

    WEST CHINA HOSPITAL, SICHUAN UNIVERSITY · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  14. US 11458174

    Synergistic bacterial compositions and methods of production and use thereof

    Seres Therapeutics, Inc. · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  15. US 11458210

    Compounds and compositions for targeting brain injuries and methods of use thereof

    SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  16. US 11459323

    Monocyclic β-lactam compound for treating bacterial infection

    Medshine Discovery Inc. · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  17. US 11459374

    Anti-VEGF protein compositions and methods for producing the same

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 4, 2022 · Expires Sep 29, 2042

    granted
  18. AU 2021230529

    Use of compounds in the treatment of fungal infections

    BASILEA PHARMACEUTICA INTERNATIONAL AG ALLSCHWIL [CH] · Granted Sep 29, 2022 · Expires Sep 24, 2042

    granted
  19. US 11453785

    Method for producing surface-treated colored inorganic particles

    KURARAY NORITAKE DENTAL INC. · Granted Sep 27, 2022 · Expires Sep 22, 2042

    granted
  20. US 11453725

    Methods for DNA-dependent targeting of a cell permeant antibody

    United States Government as represented by the Department of Veterans Affairs · Granted Sep 27, 2022 · Expires Sep 22, 2042

    granted
  21. US 11453870

    Ligase fusion proteins and application thereof

    GENEQUANTUM HEALTHCARE (SUZHOU) CO., LTD. · Granted Sep 27, 2022 · Expires Sep 22, 2042

    granted
  22. US 11453891

    Directed editing of cellular RNA via nuclear delivery of CRISPR/CAS9

    The Regents of the University of California · Granted Sep 27, 2022 · Expires Sep 22, 2042

    granted
  23. US 11453700

    Peptide having activities of skin whitening and uses thereof

    CAREGEN CO., LTD. · Granted Sep 27, 2022 · Expires Sep 22, 2042

    granted
  24. US 11453702

    Bicyclic peptide ligands specific for Nectin-4

    BicycleTx Limited · Granted Sep 27, 2022 · Expires Sep 22, 2042

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.